공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

GMP 검사 서비스 시장 : 성장, 동향, 예측(2020-2025년)

GMP Testing Service Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 05월 상품 코드 964948
페이지 정보 영문
가격
US $ 4,250 ₩ 5,044,000 PDF (Single User License)
US $ 4,750 ₩ 5,637,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,121,000 PDF (Site License)
US $ 7,500 ₩ 8,901,000 PDF (Corporate License)


GMP 검사 서비스 시장 : 성장, 동향, 예측(2020-2025년) GMP Testing Service Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

GMP 검사 서비스 시장 규모는 제약 업계 성장과 새로운 기기나 의약품 개발 필요성 증가에 의해, 예측기간 중 6.5%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예측됩니다. European Federation of Pharmaceutical Industries and Associations에 의하면, 2017년 세계 제약 업계의 총 판매량은 약 8,526억 4,700만 달러를 기록했습니다. 또한 International Journal of Environmental Research and Public Health가 발표한 연구에 의하면, 매년 약 40개 의약품이 미국과 한국에서 리콜되고 있습니다. 이로 인해 제품과 제조 프로세스 검사 필요성이 높아지고 있습니다. 또, 이러한 서비스를 아웃소싱함으로써 기업은 설비투자를 줄일 수 있습니다. 따라서, 이러한 요인은 GMP 검사 서비스 시장 성장에서 큰 역할을 할 것으로 예측됩니다. 그러나, GMP 외부 위탁에 관한 규제 프레임워크가 실제 요구하고 있는 요건이 시장 성장을 방해할 가능성이 있습니다.

세계의 GMP 검사 서비스(GMP Testing Service) 시장에 대해 조사했으며, 시장 개요, 서비스 유형별·최종사용자별·지역별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 시장 역학

  • 시장 개요
  • 시장 추진력
    • 성장하는 제약 업계
    • 의약품과 기기 개발 증가
  • 시장 억제요인
    • 엄격한 규제 프레임워크
  • Porter의 산업 분석

제5장 시장 세분화

  • 서비스 유형별
    • 제품 타당성 확인 검사
    • 생물 분석 서비스
    • 포장 및 수명 검사
    • 기타
  • 최종사용자별
    • 제약회사 및 바이오의약품 기업
    • 의료기기 제조업체
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타

제6장 경쟁 구도

  • 기업 개요
    • Eurofins Scientific
    • PPD Inc.
    • Microchem Laboratory
    • Sartorius AG
    • North American Science Associates Inc.
    • Covance, Inc.
    • Nelson Laboratories LLC
    • Almac Group
    • Pace Analytical
    • Wuxi AppTec

제7장 시장 기회와 향후 동향

LSH 20.11.12

The GMP testing service market is expected to register a CAGR of 6.5% during the forecast period due to the growing pharmaceutical industry and the increasing need for developing novel devices and drugs. According to the European Federation of Pharmaceutical Industries and Associations, the overall sales of the pharmaceutical industry worldwide were recorded to be approximately USD 852,647 million in 2017. Furthermore, according to the International Journal of Environmental Research and Public Health's published study, around 40 medications are recalled per year in the United States and South Korea. This emerges the need for testing the products and the manufacturing process. Furthermore, outsourcing these services enables companies to reduce capital investments. Hence, these factors are expected to play a major role in the GMP testing services market growth. However, the precise requirement of the regulatory framework concerning GMP outsourced activities may hinder the market growth.

Key Market Trends

Pharmaceutical and Biopharmaceutical Companies Segment is Expected to Hold a Major Market Share in the GMP Testing Service Market

  • The novel drug development in the pharmaceutical and biopharmaceutical industry is expected to drive the market growth in this segment. According to the study published by the Journal of Industrial Microbiology & Biotechnology, almost 300 biopharmaceuticals have been patented in the last three decades. The economic output of the biopharmaceutical industry was accounted to be USD 1.3 trillion in 2015, according to the International Trade Administration. This demands more quality and safety management of products, which is expected to increase GMP testing services.
  • Moreover, according to the US FDA (Food & Drug Administration) list of GMP facilities, there are around 3,652 facilities related to packaging, analytical testing in 36 countries. Approximately 2,515 facilities in the list accounted for API production facilities and finished dosage form facilities. Thus, the pharmaceutical and biopharmaceutical companies segment is expected to positively impact the GMP testing services market growth.

North America is Expected to Hold a Significant Share in the Market and is Expected to do Same in the Forecast Period.

North America is expected to be a dominant region in the GMP testing services market due to the emerging need for developing new drugs and devices. According to the Centre for Disease Control and Prevention, around USD 3.5 trillion of the amount is spent on chronic diseases in the United States. According to the same source, around 859,000 people die due to heart stroke in the United States. The number of increasing drug manufacturing plants is expected to drive the GMP testing services market growth. According to the United States Food & Drug Administration (FDA), the United States had approximately 4,676 manufacturing sites for drugs. Hence, these factors demand developing new drugs and are expected to boost the demand for GMP testing services market growth.

Competitive Landscape

The GMP testing service market consists of several major players. In terms of market share, few of the major players are currently dominating the market. Furthermore, the companies are taking initiatives to meet the higher demand for medicines and devices. For instance, PPD, Inc., in 2018, set up a new plant facility dedicated to the testing of biologics. Some of the companies which are currently dominating the market are Eurofins Scientific, PPD, Inc., Microchem Laboratory, Sartorius AG, North American Science Associates Inc., Covance, Inc., Nelson Laboratories, LLC, Almac Group, Pace Analytical, and Wuxi AppTec.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Pharmaceutical Industry
    • 4.2.2 Increasing Drug and Devices Development
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Service Type
    • 5.1.1 Product Validation Testing
    • 5.1.2 Bioanalytical Services
    • 5.1.3 Packaging and Shelf-Life Testing
    • 5.1.4 Other Service Types
  • 5.2 By End User
    • 5.2.1 Pharmaceutical and Biopharmaceutical Companies
    • 5.2.2 Medical Devices Company
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Eurofins Scientific
    • 6.1.2 PPD Inc.
    • 6.1.3 Microchem Laboratory
    • 6.1.4 Sartorius AG
    • 6.1.5 North American Science Associates Inc.
    • 6.1.6 Laboratory Corporation of America Holdings (Covance Inc.)
    • 6.1.7 Sotera Health (Nelson Laboratories LLC)
    • 6.1.8 Almac Group
    • 6.1.9 Pace Analytical
    • 6.1.10 Wuxi AppTec
    • 6.1.11 Intertek Group Plc
    • 6.1.12 Charles River Laboratories

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q